Li Li

机构：Shanxi Medical University, Dalian Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, National Cancer Center, West China Hospital of Sichuan University, Bristol-Myers Squibb (United States), Second Affiliated Hospital of Dalian Medical University, Nanjing Drum Tower Hospital, Jiangsu Cancer Hospital · ORCID：0000-0001-7536-2901

发表论文 60 篇 · 总被引 2564 次 · h-index 14

代表论文

• Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1 (2023 · Journal of Thoracic Oncology · 被引 77)
• SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer (2023 · Translational Oncology · 被引 22)
• Ultrasound-guided core-needle biopsy for peripheral pulmonary lesions: a systematic review and meta-analysis (2023 · Clinical Radiology · 被引 14)
• A systematic review and meta-analysis of neoadjuvant chemoimmunotherapy in stage III non-small cell lung cancer (2022 · BMC Pulmonary Medicine · 被引 14)
• Development and validation of a transformer-based CAD model for improving the consistency of BI-RADS category 3–5 nodule classification among radiologists: a multiple center study (2023 · Quantitative Imaging in Medicine and Surgery · 被引 10)
• Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study (2024 · European Journal of Clinical Pharmacology · 被引 9)